Whereas activation of the NLRP3 inflammasome in CRC by quercetin may reduce the chemotherapeutic potential of the chemotherapeutic agent 5 fluorouracil (5‐FU) [93], suggesting its potential as a therapeutic target. Here, NLRP3 is linked to colorectal carcinoma.